| Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series JC Pearson, B Dionne, A Richterman, SJ Vidal, Z Weiss, GE Velásquez, ... Open forum infectious diseases 7 (10), ofaa415, 2020 | 43 | 2020 |
| Remdesivir in patients with estimated GFR< 30 ml/min per 1.73 m2 or on renal replacement therapy C Estiverne, IA Strohbehn, Z Mithani, JS Hirsch, R Wanchoo, PG Goyal, ... Kidney international reports 6 (3), 835-838, 2021 | 27 | 2021 |
| Contemporary pharmacotherapies for nontuberculosis mycobacterial infections: a narrative review TM Johnson, TF Byrd, WK Drummond, LM Childs-Kean, MV Mahoney, ... Infectious Diseases and Therapy 12 (2), 343-365, 2023 | 22 | 2023 |
| Treating COVID-19: Evolving approaches to evidence in a pandemic CK Lee, LT Merriam, JC Pearson, MS Lipnick, W McKleroy, EY Kim Cell Reports Medicine 3 (3), 2022 | 15 | 2022 |
| Vancomycin area under the concentration-time curve estimation using bayesian modeling versus first-order pharmacokinetic equations: a quasi-experimental study YS Alsowaida, DW Kubiak, B Dionne, MP Kovacevic, JC Pearson Antibiotics 11 (9), 1239, 2022 | 13 | 2022 |
| Evaluation of an opt-out protocol for antibiotic de-escalation in patients with suspected sepsis: a multicenter, randomized, controlled trial RW Moehring, ME Yarrington, BG Warren, Y Lokhnygina, E Atkinson, ... Clinical Infectious Diseases 76 (3), 433-442, 2023 | 12 | 2023 |
| Evaluation of vancomycin accumulation in patients with obesity MS Assadoon, JC Pearson, DW Kubiak, MP Kovacevic, BW Dionne Open Forum Infectious Diseases 9 (10), ofac491, 2022 | 7 | 2022 |
| Pharmacotherapeutic considerations in the treatment of nontuberculous mycobacterial infections: A primer for clinicians C Cimino, CG Rivera, JC Pearson, B Colton, D Slain, MV Mahoney Open Forum Infectious Diseases 11 (4), ofae128, 2024 | 5 | 2024 |
| Dalbavancin sequential therapy for gram-positive bloodstream infection: a multicenter observational study N Rebold, S Alosaimy, JC Pearson, B Dionne, A Taqi, A Lagnf, K Lucas, ... Infectious Diseases and Therapy 13 (3), 565-579, 2024 | 5 | 2024 |
| Treatment of Chronic Granulomatous Disease–Related Pulmonary Aspergillus Infection in Late Pregnancy JA Johnson, JC Pearson, DW Kubiak, B Dionne, SE Little, DR Wesemann Open Forum Infectious Diseases 7 (10), ofaa447, 2020 | 4 | 2020 |
| Ceftaroline-induced thrombocytopenia: a case report RS Britt, JC Pearson, MV Mahoney, AA Carlson Annals of Pharmacotherapy 53 (7), 762-763, 2019 | 4 | 2019 |
| Early Empirical Use of Broad-Spectrum Antibiotics in Sepsis JL Chang, JC Pearson, C Rhee Current Infectious Disease Reports 24 (6), 77-87, 2022 | 3 | 2022 |
| Real-World Dalbavancin Use for Serious Gram-Positive Infections: Comparing Outcomes Between People Who Use and Do Not Use Drugs S Zambrano, ML Paras, J Suzuki, JC Pearson, B Dionne, H Schrager, ... Open Forum Infectious Diseases 11 (4), ofae186, 2024 | 2 | 2024 |
| Neuroinvasive Bacillus cereus Infection in Immunocompromised Hosts: Epidemiologic Investigation of 5 Patients With Acute Myeloid Leukemia JS Little, C Coughlin, C Hsieh, M Lanza, WY Huang, A Kumar, ... Open Forum Infectious Diseases 11 (3), ofae048, 2024 | 2 | 2024 |
| Evaluating the incidence of acute kidney injury and gentamicin synergy dosing for endocarditis S Starkel, M Goodberlet, B Schuler, A Rock, JR DeGrado, JC Pearson JAC-Antimicrobial Resistance 6 (1), dlad144, 2024 | 2 | 2024 |
| Impact of a pharmacy resident on a transitions of care rotation for inpatients enrolled in an outpatient parenteral antimicrobial therapy (OPAT) program RS Britt, JC Pearson, MT LaSalvia, MV Mahoney, C McCoy, S Padival Antimicrobial Stewardship & Healthcare Epidemiology 3 (1), e111, 2023 | 2 | 2023 |
| Impact of direct disk-diffusion testing on time to optimal antibiotic therapy TA Jhaveri, A Taqi, JC Pearson, S Kanjilal Antimicrobial Stewardship & Healthcare Epidemiology 3 (1), e59, 2023 | 2 | 2023 |
| Impact of interleukin-6 receptor blockade with tocilizumab on cardiac injury in patients with COVID-19: a retrospective cohort study BN Weber, G Zhou, A Kim, JC Pearson, J Stone, M DiCarli, S Nikiforow, ... Open Forum Infectious Diseases 8 (2), ofab012, 2021 | 2 | 2021 |
| Effectiveness of ceftazidime–avibactam versus ceftolozane–tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective … RK Shields, LM Abbo, R Ackley, SL Aitken, B Albrecht, A Babiker, ... The Lancet Infectious Diseases, 2024 | 1 | 2024 |
| Evaluating Clinical Sequelae of the Carbapenem-Valproate Interaction: A Retrospective Analysis N Petrucelli, BD Hayes, N Shelat, RH Elshaboury, JC Pearson, JL Koehl Open Forum Infectious Diseases 11 (3), ofae130, 2024 | 1 | 2024 |
